ENSG vs EWTX
Ensign Group vs Edgewise Therapeutics, Inc. — AI-powered side-by-side comparison
VS
EWTX
Edgewise Therapeutics, Inc.
61
Buy
| Metric | ENSG | EWTX |
|---|
| AI Score |
69
|
61
|
| Price |
$180.10
|
$44.30
|
| P/E Ratio |
27.43×
|
-23.95×
|
| ROE |
15.4%
|
-32.1%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
14.1%
|
0.0%
|
| Debt / Equity |
0.92×
|
0.01×
|
| Dividend Yield |
0.1%
|
0.0%
|
| RSI (14) |
71.8
|
61.0
|
| Beta |
0.694
|
0.275
|
| Expected Upside |
+5.3%
|
—
|
AI Committee View
Current Innellis committee reasoning for ENSG versus EWTX.
ENSG leads by 8 points.
ENSG scores 69/100 (Buy) versus EWTX at 61/100 (Buy).
ENSG Committee View
50% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- RSI at 72 is in overbought territory — Technical
EWTX Committee View
60% agreement
5 analysts
Positive signals support the current rating — vix regime is low -- calm backdrop supports risk-taking. The committee sees sufficient evidence to maintain the constructive view.
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
- Price-to-book of 5.0x prices in significant intangible value — Value
- ROE of only -39.0% -- cheap may mean cheap for a reason — Value
- Bollinger bandwidth of 23.8% signals elevated volatility — Risk